Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Chinese Journal of Hospital Administration ; (12): 907-911, 2019.
Article in Chinese | WPRIM | ID: wpr-800879

ABSTRACT

With the rapid development of " Internet+ healthcare" , medical data has gained an ever important role. How to determine the reasonable use boundary of medical data and leverage its supporting role, has grown an urgent problem to be solved. The authors analyzed the characteristics of medical data, and held that medical data is not equivalent to information, as it does not have the characteristics of legal objects in nature. In addition, it lacks originality. Therefore it is difficult to protect through the existing rights system. However, due to its property interest and personality, the authors tried to establish a new right for protection. In the construction of such medical data right, the authors claimed that patients should be the subject of the right, and medical institutions can appropriately restrict the freedom of patients′ through reasonable use rules and legal licensing system. In this way, we can not only promote medical data sharing and the development of social health, but also fully protect the legitimate rights and interests of patients.

2.
Chinese Medical Ethics ; (6): 694-696,700, 2016.
Article in Chinese | WPRIM | ID: wpr-604522

ABSTRACT

Based on the analysis on protections of civil rights in public health crises, this paper reviewed some related issues about the right of life, personal liberty, etc. It was found that the system of emergency laws was not perfect, and the articles about basic civil rights protections among different laws was inconsistent, we are also lack of a comprehensive management department to coordinate crisis response. The government should perfect laws and adjust management functions to protect citizens’ legitimate rights.

3.
Chinese Medical Ethics ; (6)1995.
Article in Chinese | WPRIM | ID: wpr-532375

ABSTRACT

The ethical review of new drugs has already been developed in China,and played an important role in the right protection of the subject.To ensure the right of the subject is fully protected,it should be improved in the aspects of constructing a certification system of the ethics committee,maintaining independence and performing informed consent completely.

SELECTION OF CITATIONS
SEARCH DETAIL